Kalaris and AlloVir Announce Stockholder Approval of Merger

Stock Information for Kalaris Therapeu

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Kalaris Therapeu

Kalaris to Present at Noble Capital Markets 2025 Emerging Growth Equity Conference
Kalaris to Participate at Stifel Ophthalmology Forum
Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights
Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee
Kalaris Announces Closing of Merger with AlloVir
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALVR, WMPN, IPG, TURN on Behalf of Shareholders
SHAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ALVR, IPG, AVAV, WMPN to Act Now
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPG, ALVR, WMPN, AVAV on Behalf of Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.